Insulin copayment caps not associated with an increase in insulin use among commercially insured populations
A new study led by Harvard Pilgrim Health Care Institute and Duke University researchers found that state policies intended to reduce insulin out-of-pocket (OOP) costs for commercially insured people were not associated with ...
Mar 26, 2024
0
1